Skip to content

Harrow HROW Finished goods

Finished goods at other companies

Bausch + Lomb logo
Bausch + LombBLCO
$643M-5.0%
Bausch Health Companies logo
Bausch Health CompaniesBHC
$946M-2.0%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$2.94M+51.5%
PBH
Prestige Consumer HealthcarePBH
$144.16M+11.7%
Organon logo
OrganonOGN
$734M-5.5%
Viatris logo
ViatrisVTRS

Other financials

Income statement

See full
Revenue$44.2M-7.6%
Gross profit$27.0M-16.3%
Operating income-$22.1M-96.6%
Net income-$27.6M-55.2%
EPS (diluted)-$0.74-48.0%

Balance sheet

See full
Cash & equivalents$94.6M+41.8%
Total debt$308.6M-32.9%
Total equity$28.7M-49.1%
Total assets$419.5M+15.2%

Cash flow

See full
Operating cash flow-$9.0M-146%
CapEx$194.0K+14.1%
Free cash flow-$9.2M-147%

Valuation

See full
Market cap$1.59B+38.4%
Enterprise value$1.81B+13.8%
P/S5.9×+0.5×

Profitability

See full
Gross margin74.1%-0.4pp
Operating margin7.3%+5.2pp
Net margin-19.8%+18.0pp
FCF margin5.7%+5.0pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity10.7×+2.6×
Current ratio2.5×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Harrow’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Harrow's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Harrow's finished goods?
Harrow (HROW) reported finished goods of $8.43M in Q1 2026.
How has Harrow's finished goods changed year-over-year?
Harrow's finished goods increased by 54.5% year-over-year, from $5.45M to $8.43M.
What is the long-term trend for Harrow's finished goods?
Over 5 years (2020 to 2025), Harrow's finished goods has grown at a 30.8% compound annual growth rate (CAGR), from $1.44M to $5.53M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.